Obstet Gynecol 2022 May 5;139(5):821-831. Epub 2022 Apr 5.
Department of Obstetrics and Gynecology, Northwestern Feinberg School of Medicine, Chicago, Illinois; the Division of Urological Surgery, Brigham and Women's Hospital, Harvard Medical School, the Harvard Radiation Oncology Program, and the Brigham and Women's Hospital/Mass General Hospital Integrated Residency Program in Obstetrics and Gynecology, Boston, Massachusetts; the Department of Obstetrics and Gynecology, University of Tennessee Health Science Center, Memphis, Tennessee; the Department of Obstetrics and Gynecology, University of California, Los Angeles, Los Angeles, the UCSF School of Medicine, San Francisco, and the Stanford University School of Medicine, Stanford, California; the Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania; and the Division of Plastic and Reconstructive Surgery, Department of Surgery, University of Washington, Seattle, Washington.
Objective: To characterize gynecology clinical trials over time, compare gynecology subspecialties, and analyze factors associated with early discontinuation, results reporting, and publication.
Methods: We conducted a cross-sectional analysis of all gynecology trials registered on ClinicalTrials.gov between 2007 and 2020 and their resulting publications. Read More